Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as a powder for solution for injection for intramuscular and subcutaneous use. It treats infertility due to anovulation, supports controlled ovarian stimulation for assisted reproductive technologies, and addresses hypogonadotropic hypogonadism. It is derived from purified urinary extracts of postmenopausal women and is used under specialist supervision.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides reliable cold‑chain logistics for injectable biologics.

Menopur, a gonadotropin used in reproductive hormone therapy, is indicated for: - Infertility due to anovulation: stimulates follicular development to enable ovulation. - Controlled ovarian stimulation for assisted reproductive technologies (e.g., IVF): promotes multiple follicle growth for egg retrieval. - Hypogonadotropic hypogonadism: provides FSH and LH activity to restore endogenous hormone production.

Menopur may cause a range of adverse reactions, which are generally related to its hormonal activity and injection site.

Common Side Effects: - Abdominal discomfort or bloating - Injection site pain or erythema - Mild headache - Nausea - Mild ovarian hyperstimulation (e.g., mild ovarian enlargement) - Fatigue

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (OHSS) - Multiple pregnancy - Ovarian torsion - Allergic reaction or anaphylaxis - Thromboembolic events - Ectopic pregnancy

When using Menopur, several precautions should be observed to minimize risks and ensure optimal outcomes. - Dose individualization: dosing should be individualized by the prescriber based on ovarian response. - Monitoring: regular ultrasound and estradiol monitoring is required during treatment. - Risk of OHSS: patients at risk should be identified and closely observed for signs of ovarian hyperstimulation. - Pregnancy considerations: use only under specialist supervision and discontinue if contraindicated. - Contraindications: avoid in active ovarian cysts, uncontrolled thyroid disease, estrogen‑dependent tumors or severe ovarian failure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - GnRH agonists: concurrent use may exacerbate ovarian hyperstimulation. - Estrogen‑containing oral contraceptives: may blunt ovarian response. - Other gonadotropins: additive effect can increase risk of OHSS. - Anticoagulants: heightened risk of thromboembolic events when OHSS occurs.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: hormonal changes may require dose adjustment. - Corticosteroids: may influence hormone metabolism and response. - Insulin or oral hypoglycemics: monitor glucose levels due to hormonal effects.